HODGKIN DISEASE
Clinical trials for HODGKIN DISEASE explained in plain language.
Never miss a new study
Get alerted when new HODGKIN DISEASE trials appear
Sign up with your email to follow new studies for HODGKIN DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for kids with advanced hodgkin lymphoma
Disease control OngoingThis study tested a new combination of a targeted drug (brentuximab vedotin) with standard chemotherapy in 59 children and teens with advanced, newly diagnosed Hodgkin lymphoma. The goal was to find the safest dose and see how well the treatment shrinks tumors. Early results sugg…
Matched conditions: HODGKIN DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Donor immune cells take aim at Virus-Linked cancers
Disease control OngoingThis study tests whether specially trained immune cells from healthy donors can safely fight cancers and diseases caused by the Epstein-Barr virus (EBV). Participants have EBV-positive lymphoma, nasopharyngeal carcinoma, or other EBV-related conditions that returned or didn't res…
Matched conditions: HODGKIN DISEASE
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 08, 2026 12:00 UTC
-
Acupuncture may slash opioid use in blood cancer patients during chemo
Symptom relief OngoingThis study tests whether adding acupuncture to standard pain care can lower the use of opioid painkillers in people with multiple myeloma, Hodgkin disease, or non-Hodgkin lymphoma who are about to receive high-dose chemotherapy. About 299 adults will be randomly assigned to get e…
Matched conditions: HODGKIN DISEASE
Phase: PHASE3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated May 17, 2026 03:00 UTC
-
New study monitors cancer survivors for hidden late effects
Knowledge-focused OngoingThis study follows 500 adults aged 18 to 65 who finished their first chemotherapy treatment for certain cancers and are in remission. Over 5 years, researchers will check for 19 possible late side effects, like heart or lung problems, and offer follow-up care. The goal is to bett…
Matched conditions: HODGKIN DISEASE
Phase: NA • Sponsor: Centre Leon Berard • Aim: Knowledge-focused
Last updated May 17, 2026 02:59 UTC
-
Scientists hunt for hidden genes behind family blood cancers
Knowledge-focused OngoingThis study looks at people and families who may have a higher chance of getting blood cancers like leukemia or lymphoma. Researchers want to learn what genes or environmental factors might cause these cancers. Participants fill out health surveys and give blood or cheek cell samp…
Matched conditions: HODGKIN DISEASE
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 06, 2026 16:13 UTC